Edition:
United States

Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

6.29CAD
16 Feb 2018
Change (% chg)

$0.52 (+9.01%)
Prev Close
$5.77
Open
$5.78
Day's High
$6.29
Day's Low
$5.78
Volume
37,388
Avg. Vol
26,327
52-wk High
$8.00
52-wk Low
$1.62

Chart for

About

Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company offers platform technologies: Collagen matrix; Antimicrobial silicone adhesive and Medical coating... (more)
No analyst recommendations are available for .

Overall

Beta: 2.01
Market Cap(Mil.): $135.20
Shares Outstanding(Mil.): 21.49
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 46.02 17.27
EPS (TTM): -- -- --
ROI: -- 9.08 35.43
ROE: -- 13.32 17.10

BRIEF-Covalon Q1 Earnings Per Share C$0.02

* Q1 REVENUE C$6.405 MILLION VERSUS C$5.609 MILLION Source text for Eikon: Further company coverage:

Feb 12 2018

BRIEF-Covalon Says Qtrly Total Revenue Increased 1,027% To $9.8 Mln

* COVALON TECHNOLOGIES LTD - QTRLY TOTAL REVENUE INCREASED 1,027% TO $9.8 MILLION Source text for Eikon: Further company coverage:

Dec 18 2017

BRIEF-Covalon Q3 earnings per share C$0.02

* Covalon Technologies Ltd- qtrly revenue $5.9 million versus $2.6 million Source text for Eikon: Further company coverage:

Aug 21 2017

Earnings vs. Estimates

No consensus analysis data available.